002422 Stock Overview
Researches, develops, manufactures, distributes, and sells pharmaceutical products in China.
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
Sichuan Kelun Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥31.26 |
52 Week High | CN¥35.49 |
52 Week Low | CN¥21.60 |
Beta | 0.067 |
11 Month Change | -1.39% |
3 Month Change | -7.16% |
1 Year Change | 17.30% |
33 Year Change | 79.66% |
5 Year Change | 12.16% |
Change since IPO | 109.24% |
Recent News & Updates
Should You Be Adding Sichuan Kelun Pharmaceutical (SZSE:002422) To Your Watchlist Today?
Aug 16Is Sichuan Kelun Pharmaceutical (SZSE:002422) Using Too Much Debt?
Jul 12Sichuan Kelun Pharmaceutical Co., Ltd.'s (SZSE:002422) Prospects Need A Boost To Lift Shares
Jun 11An Intrinsic Calculation For Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Suggests It's 45% Undervalued
May 21Recent updates
Should You Be Adding Sichuan Kelun Pharmaceutical (SZSE:002422) To Your Watchlist Today?
Aug 16Is Sichuan Kelun Pharmaceutical (SZSE:002422) Using Too Much Debt?
Jul 12Sichuan Kelun Pharmaceutical Co., Ltd.'s (SZSE:002422) Prospects Need A Boost To Lift Shares
Jun 11An Intrinsic Calculation For Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Suggests It's 45% Undervalued
May 21Sichuan Kelun Pharmaceutical's (SZSE:002422) Earnings Are Weaker Than They Seem
May 02If EPS Growth Is Important To You, Sichuan Kelun Pharmaceutical (SZSE:002422) Presents An Opportunity
Mar 19Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Surges 25% Yet Its Low P/E Is No Reason For Excitement
Mar 04These 4 Measures Indicate That Sichuan Kelun Pharmaceutical (SZSE:002422) Is Using Debt Safely
Feb 27Shareholder Returns
002422 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 2.2% | 0.9% | -0.3% |
1Y | 17.3% | -8.6% | -18.1% |
Return vs Industry: 002422 exceeded the CN Pharmaceuticals industry which returned -11.9% over the past year.
Return vs Market: 002422 exceeded the CN Market which returned -19% over the past year.
Price Volatility
002422 volatility | |
---|---|
002422 Average Weekly Movement | 4.1% |
Pharmaceuticals Industry Average Movement | 5.2% |
Market Average Movement | 5.6% |
10% most volatile stocks in CN Market | 8.9% |
10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 002422 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002422's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 19,798 | Sichuan Liu | www.kelun.com |
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China.
Sichuan Kelun Pharmaceutical Co., Ltd. Fundamentals Summary
002422 fundamental statistics | |
---|---|
Market cap | CN¥49.73b |
Earnings (TTM) | CN¥2.67b |
Revenue (TTM) | CN¥22.04b |
18.6x
P/E Ratio2.3x
P/S RatioIs 002422 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
002422 income statement (TTM) | |
---|---|
Revenue | CN¥22.04b |
Cost of Revenue | CN¥10.49b |
Gross Profit | CN¥11.55b |
Other Expenses | CN¥8.88b |
Earnings | CN¥2.67b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 29, 2024
Earnings per share (EPS) | 1.68 |
Gross Margin | 52.41% |
Net Profit Margin | 12.11% |
Debt/Equity Ratio | 19.7% |
How did 002422 perform over the long term?
See historical performance and comparison